Quotient Limited Announces CE Mark for its SARS-CoV-2 (COVID-19) Antibody Microarray
May 01, 2020 09:00 ET
|
Quotient Limited
JERSEY, Channel Islands, May 01, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), headquartered in Eysins, Switzerland, today announced...
Quotient Limited Announces SARS-CoV-2 (COVID-19) Antibody Test Final Performance Data
April 27, 2020 16:05 ET
|
Quotient Limited
JERSEY, Channel Islands, April 27, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), headquartered in Eysins, Switzerland, today reported...
Quotient Limited Announces SARS-CoV-2 (COVID-19) Antibody Test Performance Update
April 21, 2020 16:05 ET
|
Quotient Limited
JERSEY, Channel Islands, April 21, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), headquartered in Eysins, Switzerland, today reported...